The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population-Reference-Cited by-同舟云学术

The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population

Published:2014-04-12 Issue:17 Volume:23 Page:4703-4709
ISSN:0964-6906
Container-title:Human Molecular Genetics
language:en
Short-container-title:Human Molecular Genetics

Author:

Song H.,Cicek M. S.,Dicks E.,Harrington P.,Ramus S. J.,Cunningham J. M.,Fridley B. L.,Tyrer J. P.,Alsop J.,Jimenez-Linan M.,Gayther S. A.,Goode E. L.,Pharoah P. D. P.

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/23/17/4703/2206466/ddu172.pdf

Reference49 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

2. Cancer statistics, 2013

3. BRCACarriers, Prophylactic Salpingo-Oophorectomy and Menopause: Clinical Management Considerations and Recommendations

4. Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

5. A systematic review and meta-analysis of family history and risk of ovarian cancer

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of ubiquitin markers for survival and prognosis of ovarian cancer;Heliyon;2024-09

2. Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy;Obstetrics & Gynecology Science;2024-07-15

3. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions;The American Journal of Human Genetics;2024-06

4. The Molecular Detection of Germline Mutations in the BRCA1 and BRCA2 Genes Associated with Breast and Ovarian Cancer in a Romanian Cohort of 616 Patients;Current Issues in Molecular Biology;2024-05-12

5. Comprehensive Genomic Characterization in Ovarian Low-Grade and Chemosensitive and Chemoresistant High-Grade Serous Carcinomas;Oncology;2024-05-03